172 related articles for article (PubMed ID: 30726946)
1. Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance).
Morales-Oyarvide V; Yuan C; Babic A; Zhang S; Niedzwiecki D; Brand-Miller JC; Sampson-Kent L; Ye X; Li Y; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Ogino S; Wu K; Willett WC; Giovannucci EL; Wolpin BM; Meyerhardt JA; Fuchs CS; Ng K
J Natl Cancer Inst; 2019 Feb; 111(2):170-179. PubMed ID: 30726946
[TBL] [Abstract][Full Text] [Related]
2. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Meyerhardt JA; Sato K; Niedzwiecki D; Ye C; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Wigler DS; Venook A; Fuchs CS
J Natl Cancer Inst; 2012 Nov; 104(22):1702-11. PubMed ID: 23136358
[TBL] [Abstract][Full Text] [Related]
3. Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
Fadelu T; Zhang S; Niedzwiecki D; Ye X; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson AB; Atienza DM; Messino M; Kindler HL; Venook A; Ogino S; Ng K; Wu K; Willett W; Giovannucci E; Meyerhardt J; Bao Y; Fuchs CS
J Clin Oncol; 2018 Apr; 36(11):1112-1120. PubMed ID: 29489429
[TBL] [Abstract][Full Text] [Related]
4. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
Meyerhardt JA; Niedzwiecki D; Hollis D; Saltz LB; Hu FB; Mayer RJ; Nelson H; Whittom R; Hantel A; Thomas J; Fuchs CS
JAMA; 2007 Aug; 298(7):754-64. PubMed ID: 17699009
[TBL] [Abstract][Full Text] [Related]
5. Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance).
Guercio BJ; Zhang S; Niedzwiecki D; Li Y; Babic A; Morales-Oyarvide V; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Ogino S; Zoltick ES; Stampfer M; Ng K; Wu K; Willett WC; Giovannucci EL; Meyerhardt JA; Fuchs CS
PLoS One; 2018; 13(7):e0199244. PubMed ID: 30024889
[TBL] [Abstract][Full Text] [Related]
6. Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance).
Fuchs MA; Yuan C; Sato K; Niedzwiecki D; Ye X; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Innocenti F; Warren RS; Bertagnolli MM; Ogino S; Giovannucci EL; Horvath E; Meyerhardt JA; Ng K
Ann Oncol; 2017 Jun; 28(6):1359-1367. PubMed ID: 28327908
[TBL] [Abstract][Full Text] [Related]
7. Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).
Singh PP; Shi Q; Foster NR; Grothey A; Nair SG; Chan E; Shields AF; Goldberg RM; Gill S; Kahlenberg MS; Sinicrope FA; Sargent DJ; Alberts SR
Oncologist; 2016 Dec; 21(12):1509-1521. PubMed ID: 27881709
[TBL] [Abstract][Full Text] [Related]
8. Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance).
Guercio BJ; Sato K; Niedzwiecki D; Ye X; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Hu FB; Ogino S; Wu K; Willett WC; Giovannucci EL; Meyerhardt JA; Fuchs CS
J Clin Oncol; 2015 Nov; 33(31):3598-607. PubMed ID: 26282659
[TBL] [Abstract][Full Text] [Related]
9. The Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance).
Cheng E; Zhang S; Ou FS; Mullen B; Ng K; Saltz LB; Niedzwiecki D; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Giovannucci EL; Van Blarigan EL; Meyerhardt JA; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1692-1695. PubMed ID: 32499312
[TBL] [Abstract][Full Text] [Related]
10. Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
Ng K; Ogino S; Meyerhardt JA; Chan JA; Chan AT; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Benson AB; Schaefer PL; Whittom R; Hantel A; Goldberg RM; Bertagnolli MM; Venook AP; Fuchs CS
J Natl Cancer Inst; 2011 Oct; 103(20):1540-51. PubMed ID: 21849660
[TBL] [Abstract][Full Text] [Related]
11. Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).
Cheng E; Ou FS; Ma C; Spiegelman D; Zhang S; Zhou X; Bainter TM; Saltz LB; Niedzwiecki D; Mayer RJ; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Giovannucci EL; Van Blarigan EL; Brown JC; Ng K; Gross CP; Meyerhardt JA; Fuchs CS
J Clin Oncol; 2022 Mar; 40(7):740-751. PubMed ID: 34995084
[TBL] [Abstract][Full Text] [Related]
12. Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance).
Fuchs MA; Sato K; Niedzwiecki D; Ye X; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Ogino S; Wu K; Willett WC; Giovannucci EL; Meyerhardt JA
PLoS One; 2014; 9(6):e99816. PubMed ID: 24937507
[TBL] [Abstract][Full Text] [Related]
13. Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.
Van Blarigan EL; Fuchs CS; Niedzwiecki D; Zhang S; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Ogino S; Giovannucci EL; Ng K; Meyerhardt JA
JAMA Oncol; 2018 Jun; 4(6):783-790. PubMed ID: 29710284
[TBL] [Abstract][Full Text] [Related]
14. KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX.
Lee DW; Kim KJ; Han SW; Lee HJ; Rhee YY; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
Ann Surg Oncol; 2015 Jan; 22(1):187-94. PubMed ID: 24889488
[TBL] [Abstract][Full Text] [Related]
15. Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance).
Lee S; Zhang S; Ma C; Ou FS; Wolfe EG; Ogino S; Niedzwiecki D; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Gross CP; Irwin ML; Meyerhardt JA; Fuchs CS
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34104867
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
[TBL] [Abstract][Full Text] [Related]
17. Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance).
Lee S; Ma C; Shi Q; Meyers J; Kumar P; Couture F; Kuebler P; Krishnamurthi S; Lewis D; Tan B; O'Reilly EM; Shields AF; Meyerhardt JA
Br J Cancer; 2023 Aug; 129(2):283-290. PubMed ID: 37179438
[TBL] [Abstract][Full Text] [Related]
18. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
[TBL] [Abstract][Full Text] [Related]
19. Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance).
Van Blarigan EL; Ou FS; Niedzwiecki D; Zhang S; Fuchs CS; Saltz L; Mayer RJ; Venook A; Ogino S; Song M; Benson A; Hantel A; Atkins JN; Giovannucci EL; Meyerhardt JA
Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1227-1230. PubMed ID: 30038051
[No Abstract] [Full Text] [Related]
20. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]